Drug Trial Radar · NCT07363577
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
456
Planned (sponsor's estimate)
Start
Mar 25, 2026
Primary completion
Jun 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- LB Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the treatment of adult patients with an acute exacerbation of schizophrenia.
Conditions
- Schizophrenia
Interventions
LB-102 (50 mg tablet)Drug
LB-102 oral tablet given for six weeks
LB-102 (100 mg tablet)Drug
LB-102 oral tablet given for six weeks
PlaceboOther
Placebo tablet given orally for six weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to Week 6 on the Positive and Negative Syndrome ScaleTime frame: 6 weeks
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Pillar Clinical Research
Bentonville, Arkansas · Recruiting
Pillar Clinical Research
Little Rock, Arkansas · Recruiting
Woodland International Research Group
Little Rock, Arkansas · Recruiting
ProScience Research Group
Culver City, California · Recruiting
CenExel
Garden Grove, California · Recruiting
Synergy San Diego
Lemon Grove, California · Recruiting
Clinical Innovations, Inc.
Riverside, California · Recruiting
Health Synergy Clinical Research
Boynton Beach, Florida · Recruiting
Innovative Clinical Research
Miami Lakes, Florida · Recruiting
Accelerated Clinical Trial
Snellville, Georgia · Recruiting
Pillar Clinical Research
Chicago, Illinois · Recruiting
Arch Clinical Trials
St Louis, Missouri · Recruiting
Neuro-Behavioral Clinical Research
North Canton, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.